Clinical studies have demonstrated that adiponectin is elevated in patients with chronic kidney disease, suggesting a possible compensatory upregulation to alleviate further renal injury (Christou and Kiortsis, 2014). The gene discussed is ADIPOQ; the disease is chronic kidney disease.